MarketInOut Stock Screener Log In | Sign Up

Lyka Labs Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:32
Lyka Labs Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization2,981.54 mln
Float30.29 mln
Earnings Date10/30/2026

EPS

0.59
Stretched

P / E

136
Highly speculative

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.24
Reliable

Relative Strength

95 / 100
Top performer

Debt / Equity

0.53
Moderate leverage

Business Description

Founded in 1976 and headquartered in Mumbai, Lyka Labs Limited is an Indian pharmaceutical company that produces and sells a wide range of medicines and health products. Its portfolio covers treatments for skin conditions, pain, infections, hormonal disorders, liver disease, and more, available in forms such as injections, creams, gels, and lotions. The company also provides scientific data services, including stability testing and clinical study data, and distributes its products both within India and internationally.

Key Fundamentals

EPS0.59
P/E136
ROE-8.95
RPS36.76
ROIC-6.03
ROA-5.15
Interest Cover-3.36
EBITDA, mln4.89
EV / EBITDA704
EV / EBIT-43.75
Revenue, mln1,377
EV / Revenue2.50

Quote Details

Last 80.24
Change -1.63 (-1.99%)
Open 80.24
Volume 136
Turnover 10,913
Average Volume 5,961.38

Financial Ratios

Pre-Tax Profit Margin-8
Current Ratio1.17
Price / Book3.30
Price / Tangible Book3.57
Price / Cash Flow21.40
Price / Free Cash Flow56.90
Debt / Equity0.53
Price / Sales2.19

Financial Strength

Altman Z-Score1.73
Piotroski F-Score 2 / 9
Beneish M-Score-3.24
Price to Intrinsic Value4.85

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.77% 22 / 100   
1 Month -6.91% 50 / 100   
2 Months 16.12% 87 / 100   
6 Months 37.51% 89 / 100   
1 Year -15.27% 54 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog